- Novo Nordisk ourselves ourselves the boss while Ozempic Maker beats collapses Financial time
- The CEO of Novo Nordisk moves to the surprise decision while the “market challenges” weigh on the obesity of medication Yahoo Finance
- Wegovy Maker Novo Nordisk CEO to resign Axios
- The CEO of Novo Nordisk, Jorgensen, left after the fall in the course of action Bloomberg.com
- The manufacturer of obesity drugs Novo Nordisk Ouvalise the CEO while the competition weighs Reuters